Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia
Falkenburg, J.H. Frederik ; Smit, Willem M. ; Willemze, Roel
Oxford, UK : Blackwell Publishing Ltd
Published 1997
Oxford, UK : Blackwell Publishing Ltd
Published 1997
| ISSN: |
1600-065X
|
|---|---|
| Source: |
Blackwell Publishing Journal Backfiles 1879-2005
|
| Topics: |
Medicine
|
| Notes: |
Summary: In addition lo chemotherapy and irradiation, in the context of allogeneic stem cell transplantation (SCT), the donor cell-mediated anti-leukemic effect can lead to sustained complete remissions, also in cases of a large tumor load. This phenomenon appears to be an immunologically mediated response, possibly due to various effector cell populations. Cytotoxic T-lymphocyte (CTL) responses against minor histocompatibility antigens with restricted tissue distribution, in particular restricted to some or all hematopoietic cells, may be highly efficient in inducing and-leukemic responses for adoptive immunotherapy Specific CTL responses against leukemia-associated antigens may be generated using leukemic cells modified to co-express costimulatory molecules identical to professional antigens may be used in the context of allogeneic tells Donor derived T cell recognizing such antigens may be used in the context of allogeneic SCT to induce complete and sustained remissions, also in patients with leukemia refractory to chemotherapy. In these to circumstances, the primary objective of allogeneic SCT may be not to diminish the number of malignant cells by the chemotherapy and irradiation as part of the conditioning regimen, but to allow immunotherapy against leukemic cells using donor lymphocyte populations.
|
| Type of Medium: |
Electronic Resource
|
| URL: |
| _version_ | 1798290493964025856 |
|---|---|
| autor | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel |
| book_url | http://dx.doi.org/10.1111/j.1600-065X.1997.tb00985.x |
| datenlieferant | nat_lic_papers |
| hauptsatz | hsatz_simple |
| identnr | NLZ242667872 |
| insertion_date | 2012-04-27 |
| issn | 1600-065X |
| journal_name | Immunological reviews |
| materialart | 1 |
| notes | Summary: In addition lo chemotherapy and irradiation, in the context of allogeneic stem cell transplantation (SCT), the donor cell-mediated anti-leukemic effect can lead to sustained complete remissions, also in cases of a large tumor load. This phenomenon appears to be an immunologically mediated response, possibly due to various effector cell populations. Cytotoxic T-lymphocyte (CTL) responses against minor histocompatibility antigens with restricted tissue distribution, in particular restricted to some or all hematopoietic cells, may be highly efficient in inducing and-leukemic responses for adoptive immunotherapy Specific CTL responses against leukemia-associated antigens may be generated using leukemic cells modified to co-express costimulatory molecules identical to professional antigens may be used in the context of allogeneic tells Donor derived T cell recognizing such antigens may be used in the context of allogeneic SCT to induce complete and sustained remissions, also in patients with leukemia refractory to chemotherapy. In these to circumstances, the primary objective of allogeneic SCT may be not to diminish the number of malignant cells by the chemotherapy and irradiation as part of the conditioning regimen, but to allow immunotherapy against leukemic cells using donor lymphocyte populations. |
| package_name | Blackwell Publishing |
| publikationsjahr_anzeige | 1997 |
| publikationsjahr_facette | 1997 |
| publikationsjahr_intervall | 8004:1995-1999 |
| publikationsjahr_sort | 1997 |
| publikationsort | Oxford, UK |
| publisher | Blackwell Publishing Ltd |
| reference | 157 (1997), S. 0 |
| search_space | articles |
| shingle_author_1 | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel |
| shingle_author_2 | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel |
| shingle_author_3 | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel |
| shingle_author_4 | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel |
| shingle_catch_all_1 | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia Blackwell Publishing Ltd Summary: In addition lo chemotherapy and irradiation, in the context of allogeneic stem cell transplantation (SCT), the donor cell-mediated anti-leukemic effect can lead to sustained complete remissions, also in cases of a large tumor load. This phenomenon appears to be an immunologically mediated response, possibly due to various effector cell populations. Cytotoxic T-lymphocyte (CTL) responses against minor histocompatibility antigens with restricted tissue distribution, in particular restricted to some or all hematopoietic cells, may be highly efficient in inducing and-leukemic responses for adoptive immunotherapy Specific CTL responses against leukemia-associated antigens may be generated using leukemic cells modified to co-express costimulatory molecules identical to professional antigens may be used in the context of allogeneic tells Donor derived T cell recognizing such antigens may be used in the context of allogeneic SCT to induce complete and sustained remissions, also in patients with leukemia refractory to chemotherapy. In these to circumstances, the primary objective of allogeneic SCT may be not to diminish the number of malignant cells by the chemotherapy and irradiation as part of the conditioning regimen, but to allow immunotherapy against leukemic cells using donor lymphocyte populations. 1600-065X 1600065X |
| shingle_catch_all_2 | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia Blackwell Publishing Ltd Summary: In addition lo chemotherapy and irradiation, in the context of allogeneic stem cell transplantation (SCT), the donor cell-mediated anti-leukemic effect can lead to sustained complete remissions, also in cases of a large tumor load. This phenomenon appears to be an immunologically mediated response, possibly due to various effector cell populations. Cytotoxic T-lymphocyte (CTL) responses against minor histocompatibility antigens with restricted tissue distribution, in particular restricted to some or all hematopoietic cells, may be highly efficient in inducing and-leukemic responses for adoptive immunotherapy Specific CTL responses against leukemia-associated antigens may be generated using leukemic cells modified to co-express costimulatory molecules identical to professional antigens may be used in the context of allogeneic tells Donor derived T cell recognizing such antigens may be used in the context of allogeneic SCT to induce complete and sustained remissions, also in patients with leukemia refractory to chemotherapy. In these to circumstances, the primary objective of allogeneic SCT may be not to diminish the number of malignant cells by the chemotherapy and irradiation as part of the conditioning regimen, but to allow immunotherapy against leukemic cells using donor lymphocyte populations. 1600-065X 1600065X |
| shingle_catch_all_3 | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia Blackwell Publishing Ltd Summary: In addition lo chemotherapy and irradiation, in the context of allogeneic stem cell transplantation (SCT), the donor cell-mediated anti-leukemic effect can lead to sustained complete remissions, also in cases of a large tumor load. This phenomenon appears to be an immunologically mediated response, possibly due to various effector cell populations. Cytotoxic T-lymphocyte (CTL) responses against minor histocompatibility antigens with restricted tissue distribution, in particular restricted to some or all hematopoietic cells, may be highly efficient in inducing and-leukemic responses for adoptive immunotherapy Specific CTL responses against leukemia-associated antigens may be generated using leukemic cells modified to co-express costimulatory molecules identical to professional antigens may be used in the context of allogeneic tells Donor derived T cell recognizing such antigens may be used in the context of allogeneic SCT to induce complete and sustained remissions, also in patients with leukemia refractory to chemotherapy. In these to circumstances, the primary objective of allogeneic SCT may be not to diminish the number of malignant cells by the chemotherapy and irradiation as part of the conditioning regimen, but to allow immunotherapy against leukemic cells using donor lymphocyte populations. 1600-065X 1600065X |
| shingle_catch_all_4 | Falkenburg, J.H. Frederik Smit, Willem M. Willemze, Roel Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia Blackwell Publishing Ltd Summary: In addition lo chemotherapy and irradiation, in the context of allogeneic stem cell transplantation (SCT), the donor cell-mediated anti-leukemic effect can lead to sustained complete remissions, also in cases of a large tumor load. This phenomenon appears to be an immunologically mediated response, possibly due to various effector cell populations. Cytotoxic T-lymphocyte (CTL) responses against minor histocompatibility antigens with restricted tissue distribution, in particular restricted to some or all hematopoietic cells, may be highly efficient in inducing and-leukemic responses for adoptive immunotherapy Specific CTL responses against leukemia-associated antigens may be generated using leukemic cells modified to co-express costimulatory molecules identical to professional antigens may be used in the context of allogeneic tells Donor derived T cell recognizing such antigens may be used in the context of allogeneic SCT to induce complete and sustained remissions, also in patients with leukemia refractory to chemotherapy. In these to circumstances, the primary objective of allogeneic SCT may be not to diminish the number of malignant cells by the chemotherapy and irradiation as part of the conditioning regimen, but to allow immunotherapy against leukemic cells using donor lymphocyte populations. 1600-065X 1600065X |
| shingle_title_1 | Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia |
| shingle_title_2 | Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia |
| shingle_title_3 | Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia |
| shingle_title_4 | Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia |
| sigel_instance_filter | dkfz geomar wilbert ipn albert |
| source_archive | Blackwell Publishing Journal Backfiles 1879-2005 |
| timestamp | 2024-05-06T08:17:37.083Z |
| titel | Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia |
| titel_suche | Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia |
| topic | WW-YZ |
| uid | nat_lic_papers_NLZ242667872 |